Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

SODIUM CHLORIDE INJECT

Active
SPE2DP-26-T-5235Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Solicitation SPE2DP-26-T-5235 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Sodium Chloride Injection. The required product is a 0.9 percent concentration, 100 ML in a 150 ML fill plastic container, identified by NSN 6505-01-330-8924. The procurement consists of three line items with total quantities of 11 packages, where one package equals 64 units. Delivery is required within five days after the order, with the destination for delivery, inspection, and acceptance located at Fort Bragg, North Carolina. The contract mandates strict adherence to Medical Marking Standard No. 1, requiring labels to include the NSN, manufacturer and CAGE code, date of manufacture, expiration or retest date, and the contract or lot number. Packaging must be commercial and comply with MIL-STD-2073-1E, utilizing sealed unit containers and suitable exterior shipping containers to prevent damage. The product is FDA regulated and has a non-extendable shelf life of 15 months, requiring storage at a room temperature of 25 degrees Celsius away from excessive heat. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and payment requests. The solicitation incorporates the DLA Master Solicitation for Automated Simplified Acquisitions Revision 105 and includes various FAR and DFARS clauses regarding cybersecurity, the Buy American Act, and the safeguarding of covered defense information. Quotations must be submitted via the DIBBS system by September 30, 2026.

General Info

Fixed-price procurement of Sodium Chloride Injection for delivery to Fort Bragg, North Carolina.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

2530 TAYLOR STREET BLDG NUMBER 2530, FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-5235 Request for Quotations

PDF•rfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

4 updates
PhaseSolicitation
Posted

Solicitation

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
SODIUM CHLORIDE INJECTION
SODIUM CHLORIDE INJECTION
0.9%, 100 ML IN 150 ML FILL PLASTIC CONTAINER 64'S
. U/I "PG" (64'S)
Avoid excessive heat. Store at room temperature (25°C. RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS (IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
1 PG = 64 EA
LABELING AND MARKING MUST IN ACCORDANCE WITH MEDICAL MARKING STANDARD
NO. 1A DATED 4 FEBRUARY 2013. LABELS SHALL INCLUDE: NSN MANUFACTURER AND
CAGE DATE OF MANUFACTURE, EXPIRATION, OR RETEST DATE CONTRACT NUMBER/LOT
NUMBER.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS012: Shelf-life requirement RS001 for a TYPE I (CODE J) item with a
SPE2DP-26-T-5235
SECTION B
shelf life of 15 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
B. BRAUN MEDICAL INC 11171 P/N NDC00264-1800-32 B. BRAUN MEDICAL INC 11171 P/N S8004-5264
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018502008 0001 PG 2.000
NSN/MATERIAL:6505013308924
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-330-8924 Quantity: 2 PG Purchase Request: 7018501943QTY: 4 Delivery: 5 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
6505--Prednisolone 1% Ophthalmic Solution
Solicitation # 36E79726R0037
The Department of Veterans Affairs Enterprise Procurement Office is initiating an unrestricted procurement under solicitation 36E79726R0037 for Prednisolone Acetate 1% Ophthalmic Suspension. This contract aims to establish an uninterrupted source of supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers, with distribution managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The award will be granted to a single responsible offeror for a base period of one year, with four subsequent pre-priced one-year option periods. Estimated annual requirements include 392,107 bottles of the 5ml size, 70,070 bottles of the 10ml size, and 10,172 bottles of the 15ml size. The procurement is conducted in commercial item format per FAR Part 12 under NAICS code 325412. Strict labeling and packaging standards are required: offerors must provide a unique NDC number, and the contractor's label must be the only label on the product, with no over-labeling permitted. Bottles must accommodate a label measuring 5.25 by 2 inches, including an additional 0.5 inch of space to keep barcodes, lot numbers, and expiration dates exposed, while ensuring VA labels can securely adhere on top. The RFP is expected to be issued around October 1, 2026, with a tentative closing date of October 15, 2026. All submissions and updates will be handled electronically via SAM.gov.
Nac Pharmaceuticals (36E797)

POSTED

about 22 hours ago

DEADLINE

in 19 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS